Search

Your search keyword '"Gopalan, Anuradha"' showing total 633 results

Search Constraints

Start Over You searched for: Author "Gopalan, Anuradha" Remove constraint Author: "Gopalan, Anuradha"
633 results on '"Gopalan, Anuradha"'

Search Results

152. Clinical utility of subclassifying positive surgical margins at radical prostatectomy.

158. PD-1 Blockade in Advanced Adrenocortical Carcinoma

159. Morphologic and Immunohistochemical Assessment of CDH1 Loss of Function Alterations in Prostatic Adenocarcinoma

162. The Immune Landscape of Cancer

163. Abstract 111: Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer

164. Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma.

165. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder

167. Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

168. MP16-18 MOLECULAR STRATIFICATION OF HIGH-GRADE UNCLASSIFIED RENAL CELL CARCINOMA TO IMPROVE PROGNOSTICATION AND MANAGEMENT

170. Molecular stratification of high-grade unclassified renal cell carcinoma to improve prognostication and management strategy.

171. Clinicopathologic and genomic characterization of parenchymal brain metastases (BM) in prostate cancer (PCa).

172. Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer

173. The Diagnostic Accuracy of Percutaneous Renal Needle Core Biopsy and Its Potential Impact on the Clinical Management of Renal Cortical Neoplasms

174. Prognostic and therapeutic significance of COP9 signalosome subunit CSN5in prostate cancer

175. CD274(PD-L1) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract

176. PD-L1 Expression in Urothelial Carcinoma with Divergent Differentiation, Concordance among Three Antibodies

177. Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075))

178. Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors

180. Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer

183. Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer

185. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

186. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

187. Abstract A074: Aberrant activation of a gastrointestinal transcriptional circuit in prostate cancer mediates castration resistance

188. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

189. Comprehensive Characterization of Cancer Driver Genes and Mutations

190. Comedonecrosis Revisited

191. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

192. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features

194. Microsatellite instability in prostate cancer and response to immune checkpoint blockade.

195. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

196. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

197. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

198. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

199. Oncogenic Signaling Pathways in The Cancer Genome Atlas

200. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

Catalog

Books, media, physical & digital resources